EXCLUSIVE
The DM-Flow (TM-Flow + ETF) devices are both non-invasive diagnostic tools used in Primary Care, Endocrinology, Cardiology, and Podiatry clinics to assess vascularization, vascular function, and autonomic nervous system performance. They provide healthcare providers with insights into a patient’s risk for cardiovascular disease, peripheral arterial disease (PAD), and autonomic dysfunctions, including sudomotor dysfunction and loss of sensation—often associated with conditions such as diabetes, hypertension, and metabolic syndrome.
The DM-Flow devices are effective tools for early detection, risk stratification, and monitoring of chronic diseases, making it a valuable addition in any clinical setting.
DM-Flow (4-in-1) Podcast
19:01 Minutes
Note: 15 second audio delay after pressing play.Â
Listen and DiscoverÂ
Galvanic Skin Response Test & Bioimpedance Analysis
Bleeding-edge Photoplethysmography
Ankle Brachial Index & Volume Plethysmography
Vibroception of Sensory Nerves to Stimuli
The DM-Flow with the Electronic Tuning Fork (ETF)
The DM-Flow is a state-of-the-art diagnostic system designed to revolutionize patient care by providing a comprehensive and integrated approach to health assessments. Composed of five (5) assessments, the platform offers a seamless blend of cutting-edge technology and clinical precision, enabling healthcare providers to assess and monitor critical health parameters efficiently and effectively.Â
All of the assessments work together to deliver a holistic view of a patient’s health, focusing on vascular function, autonomic nervous system performance, and other vital metrics, ensuring that no aspect of patient care is overlooked. This innovative system empowers clinicians to detect early signs of chronic conditions, track disease progression, and implement preventive strategies tailored to each patient, ultimately enhancing outcomes and supporting value-based care initiatives.
TBL-ABI:
Measures Ankle Brachial Indices and volume plethysmography, essential for the early detection of Peripheral Artery Disease (PAD).
SweatC:
Assesses sudomotor function by measuring the Galvanic Skin Response, aiding in the evaluation of autonomic nervous system function.
LD-OXI:
Employs mathematical photoplethysmography analysis for two critical assessments:
Autonomic Nervous System Evaluation: Heart Rate Variability (HRV) analysis at rest and during Ewing Tests.
Endothelial Function Assessment: Through advanced Photoplethysmography (PTG) analysis.
ETF:
Measures large fiber nerves to stimuli at 128HzÂ
Wireless
Non-invasive
1-minute test
Portable (fits in pocket)
No disposables needed
Delivers quantitative documentation for EMRs
Five (5) vibration amplitude modes available: Descending, Ascending, Constant, Fx Test and Vibroception Average
Note: Results are independent of the DM-Flow platform and its results.
Note: The 128 Hz frequency is the recognized standard in the U.S. for testing peripheral neuropathy, particularly for evaluating vibration perception in large fiber nerve function. Widely endorsed by organizations such as the American Diabetes Association (ADA), CDC, and CMS guidelines.Â
Integrating DTC solutions like our All-in-One device can boost patient outcomes, streamline workflows, and increase testing and revenue by up to 4x.Â
Go Beyond the Ordinary
At DTC, we don’t just provide equipment—we invest in your clinic’s growth. From installation to staff training and beyond, we’re with you every step of the way. Think of us as an extension of your team, dedicated to making your practice thrive.
Primary Care: Comprehensive diabetes assessments and management tools.
Pharmacy: Remote services that are billable by medical providers.
Cardiology: Heart health monitoring and risk assessments.
Endocrinology: Hormonal and metabolic evaluations. :
Neurology: Neuropathy and cognitive assessments.
Podiatry: Diabetic neuropathy foot care and wound management.
These efforts aim to identify and address these conditions early, leading to improved health outcomes and more efficient care delivery. This efficiency ensures that healthcare providers' time and resources are used effectively, enhancing the overall care experience. Go Beyond Diabetes.Â
2 in 3 of Medicare Patients Have 2 or More Chronic Conditions